Essex Bio-Technology Ltd
HKEX:1061
Essex Bio-Technology Ltd
Operating Income
Essex Bio-Technology Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Essex Bio-Technology Ltd
HKEX:1061
|
Operating Income
HK$338.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Operating Income
$27.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Operating Income
-HK$106.7m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Operating Income
HK$76.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Operating Income
HK$257m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is Essex Bio-Technology Ltd's Operating Income?
Operating Income
338.9m
HKD
Based on the financial report for Dec 31, 2023, Essex Bio-Technology Ltd's Operating Income amounts to 338.9m HKD.
What is Essex Bio-Technology Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
5%
Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for Essex Bio-Technology Ltd have been 14% over the past three years , 5% over the past five years .